Skip to main content
logo
aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.4800
-0.0030 (-0.62%)
At close: Jul 30, 2026, 4:00 PM EDT
0.4800
0.00 (0.00%)
After-hours: Jul 30, 2026, 5:40 PM EDT

aTyr Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.190.240.3510.39-
Revenue Growth
--19.15%-33.43%-96.60%--
Gross Profit
-0.190.240.3510.39-
Operating Income
-73.29-77.63-67.91-54.92-46.4-34.02
Net Income
-70.03-74.12-64.02-50.39-45.34-33.77
Earnings Per Share
-0.73-0.80-0.86-0.94-1.60-1.77
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
66.5178.6972.1398.1766.15107.91
Total Debt
11.712.0313.2815.111.531.38
Net Cash (Debt)
54.8166.6558.8483.0754.61106.53
Net Cash Growth
-13.49%13.28%-29.17%52.11%-48.74%261.74%
Net Cash Per Share
0.570.720.791.551.925.58

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-59.08-61.99-69.12-33.22-41.89-33.08
Capital Expenditures
-0.22-0.08-0.07-4.22-1.64-0.19
Free Cash Flow
-59.3-62.06-69.18-37.44-43.53-33.27
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%100.00%100.00%100.00%-
Operating Margin
--40856.30%-28899.60%-15557.80%-446.79%-
Pretax Margin
--39012.11%-27243.40%-14276.77%-436.58%-
Profit Margin
--39012.10%-27243.40%-14276.80%-436.58%-
FCF Margin
--32664.70%-29440.00%-10605.10%-419.09%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
251.53404.041294.56---